Genome Ventures

General contacts

Investor type

Founded

2016

AUM

Location

Moscow, Moscow, Russia

Investment Ticket

$0-1 m

Investment Stage

Series A Seed Series B

Region of investment

Europe

Investor profile last updated: 21 August, 2026

Profile

Genome Ventures is an investment holding with a focus on empowering business teams and successful leaders. Based in an undisclosed location, the firm manages a diverse portfolio of over 15 companies. Although the founding year is not specified, Genome Ventures operates under the guidance of a leadership team whose details are not provided on the website. The firm stands out by supporting dynamic leadership and focused business teams in various sectors.

Genome Ventures invests across a wide range of sectors, but specific industries and investment ranges are not detailed on the firm's website. With over 15 portfolio companies, Genome Ventures appears to be a versatile organization. However, without specific AUM disclosures, fund names, or details of geographical focus, it is challenging to ascertain the precise investment strategies and focus areas.

Notable investments and specific portfolio companies are not listed in the information provided from the site's content. This lack of detail suggests that Genome Ventures maintains privacy around its investment activities, or the website content is currently limited in its disclosures.

Industry

Mobility HealthTech PropTech / ConTech Cybersecurity MedTech Education Edtech

Contacts

Name

Title

Social Networks

Alexander Smbatyan Founder

Founder

Anna Shtyrkova (Polishuk) Personal Assistant to CEO and Founder

Personal Assistant to CEO and Founder

Upgrade to see contacts

YaicwD0V72HXbdIz YaicwD0V72HXbdIz

YaicwD0V72HXbdIz

[email protected]

YaicwD0V72HXbdIz YaicwD0V72HXbdIz

YaicwD0V72HXbdIz

[email protected]

YaicwD0V72HXbdIz YaicwD0V72HXbdIz

YaicwD0V72HXbdIz

[email protected]

Investment-team contacts for Genome Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Genome Ventures

Is Genome Ventures a venture capital or private equity firm?

Genome Ventures is a venture capital firm. It backs companies at Series A, Seed and Series B, writing tickets of $0-1 m.

Where is Genome Ventures located?

Genome Ventures is located in Moscow, Moscow, Russia.

When was Genome Ventures founded?

Genome Ventures was founded in 2016.

What sectors and industries does Genome Ventures invest in?

Genome Ventures invests in companies and startups in Mobility, HealthTech, PropTech / ConTech, Cybersecurity, MedTech, Education, Edtech.

What is Genome Ventures geographical focus of investments?

Genome Ventures invests in companies and startups in Europe.

At what stages of companies and startups does Genome Ventures typically invest in?

Genome Ventures invests in companies and startups at Series A, Seed, Series B.

What is the usual amount of Genome Ventures investment?

Genome Ventures usually invests $0-1 m on average.

What are the contacts of Genome Ventures?

Genome Ventures can be reached through its website genomeventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Genome Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Genome Ventures data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Genome Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Genome Ventures profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.